Accelerating Innovation in Medical Devices through PCCPs and CI/CD Strategies

In the fast-evolving field of medical devices, rapid innovation is essential to ensure that these critical products meet the ever-changing needs of healthcare professionals and patients alike. To address this demand, a growing number of manufacturers are employing Predetermined Change Control Plans (PCCPs) in conjunction with Continuous Integration and Continuous Delivery (CI/CD) frameworks. An upcoming webinar hosted by Xtalks will delve into how these strategies can significantly expedite updates for software and AI/ML functionalities in medical devices.

What are PCCPs?

PCCPs are structured plans that allow medical device manufacturers to pre-authorize changes to their software, thereby streamlining regulatory submissions and reducing lengthy approval processes. By adopting a proactive approach to change management, organizations can expedite their release cycles and maintain compliance with regulations without the cumbersome wait for approvals that often spans several months.

The Role of CI/CD in Medical Device Development

CI/CD plays a crucial role in enhancing the efficiency of product updates. This methodology encompasses automation in the testing and deployment of software changes, allowing teams to validate and integrate modifications seamlessly. The integration of PCCPs into CI/CD processes not only supports rapid updates but also helps in embedding quality management throughout the development pipeline.

Key Benefits of Combining PCCPs with CI/CD

1. Faster Release Cycles: By pre-authorizing changes through PCCPs, manufacturers can sidestep the traditional lengthy approval processes, enabling quicker delivery of updated features and bug fixes.
2. Enhanced Compliance: With a clear framework in place for managing changes, compliance with regulatory guidelines becomes more straightforward, reducing the risk of violations and ensuring that patient safety remains a top priority.
3. Automated Validation: By integrating automated validation protocols into CI/CD workflows, teams can ensure that each software update meets the required standards quickly, without manual interventions that can delay releases.
4. Real-World Data Utilization: The webinar will highlight how to operationalize continuous validation using real-world data, which is essential for keeping track of model performance and detecting any potential drift in the algorithms.

Expert Insights at the Webinar

Experts from Ketryx, including Jenn Dixon, Director of AI Quality Regulatory Strategy, and Adrian Samsel, Director of Client Operations, will lead this enlightening session. They will share invaluable insights into how PCCPs can transform the landscape of medical device updates, ensuring that quality is interwoven into every stage of development.

Register Now!

Don’t miss your chance to learn how to harness the power of PCCPs combined with CI/CD to streamline the innovation processes in your organization. The webinar is scheduled for April 2, 2026, at 12 PM EDT (6 PM CEST).

Join industry leaders in this engaging session to redefine how medical device development can keep pace with current demands for speed and reliability. For more information and registration details, visit Xtalks' official website.

The demand for medical devices that are safe, effective, and innovative has never been higher. Embracing PCCPs and CI/CD can be a game-changing decision for companies looking to thrive in this competitive marketplace. Are you ready to take the leap towards innovation?